Abstract
In this issue of Blood, Dubovsky et al show that ibrutinib inhibits interleukin-2 (IL-2) inducible kinase (ITK) and thereby modulates T-cell signaling and function.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2529-2531 |
| Number of pages | 3 |
| Journal | Blood |
| Volume | 122 |
| Issue number | 15 |
| DOIs | |
| State | Published - Oct 10 2013 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology